Fall River, MA – Dacon Corporation has completed an expansion to InvaGen Pharmaceuticals’ Fall River manufacturing facility.
InvaGen is a subsidiary of Cipla (Chemical Industrial Pharmaceutical Laboratories), a global firm founded in 1935 by Dr. K.A. Hamied, whose mission was to make India self-sufficient in healthcare. Cipla manufactured the first respiratory inhalers in India, followed by the creation of the first triple HIV cocktail therapy for Doctors without Borders. This reduced AIDS treatment to $1 per day, enabling accessible therapies to underserved populations. Today Cipla’s mission of affordable, high-quality medicines spans a continuum of therapeutic categories, and its portfolio encompasses over 1,500 products in 86 countries.
Acquired in 2016 as part of a global initiative, the InvaGen Pharmaceuticals division is responsible for the research, development and manufacturing of respiratory medications for pediatric and adult use. The facility expansion is in response to employee and manufacturing growth.
